P
PepGen
IPO- Type
- Public
About
Clinical-stage biotechnology company developing therapeutics for Duchenne muscular dystrophy.
Similar Companies

Canopy Growth Corporation Common SharesIPO
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...
Smiths Falls, Canada1001–5000healthtech, Healthcare
Corporate Round·$4.5B·Jan 2024

Oscar HealthIPO
Health insurance company using technology to make health care simple, affordable, and accessible.
New York, United States1001–5000Healthcare, Insurance
Series F·$1.9B·Jun 2020

Caris Life SciencesIPO
Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...
Irving, United States1001–5000Diagnostics, Genomics
Growth Equity·$1.5B·Apr 2025
LifeStance HealthIPO
Outpatient mental health provider offering in-person and virtual therapy, psychiatry, and psychol...
Scottsdale, United States5001–10000healthtech, Healthcare
Private Equity·$1.4B·Apr 2020
Sana BiotechnologyIPO
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Seattle, United States201–500Biotech, Life Sciences
Series D·$1.4B·Jun 2020
BrightSpring Health ServicesIPO
Leading provider of diversified home and community-based health and pharmacy services to medicall...
Louisville, United States10001+healthtech, Healthcare
Private Equity·$1.3B·Mar 2019